ArticleCancers2024

Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors.

Rushabh Gujarathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.